Proton pump inhibitor therapy improves symptoms in postnasal drainage

Gastroenterology

Volumn 139, Issue 6, 2010, Pages

  Vaezi, Michael F ^a   Hagaman, David D ^a   Slaughter, James C ^a   Tanner, S Bobo ^a   Duncavage, James A ^a   Allocco, Christine T ^a   Sparkman, Christy ^a   Clement, Lynn E ^a   Wasden, Cynthia M ^a   Wirth, Dana ^a   Goutte, Marion ^a   McCafferty, Barbara A ^a   Lanza, Donald C ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Sinus and Nasal Institute of Florida   (United States)

Author keywords

Extraesophageal GERD; Gastroesophageal Reflux Disease; Impedance pH Monitoring; Randomized Controlled Trial

Indexed keywords

LANSOPRAZOLE; PLACEBO;

ADULT; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; ESOPHAGUS FUNCTION; FEMALE; FOOD REGURGITATION; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PH; PHARYNX DISCOMFORT; POSTNASAL DRAINAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 78649711053     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.08.039     Document Type: Article

References (38)

1. A.H. Morice Post nasal drip syndromea symptom to be sniffed at? Pulm Pharmacol Ther 17 2004 343 345
2. J. O'Hara, and N.S. Jones Post nasal drip syndrome: most patients with purulent nasal secretions do not complain of chronic cough Rhinology 44 2006 270 273
3. B.C. Palombini, C.A.C. Villanova, and E. Araujo A pathogenic triad in chronic cough-asthma, postnasal drip syndrome and gastroesophageal reflux disease Chest 116 1999 279 284
4. S.K. Wise, J.C. Wise, and J.M. DelGaudio Association of nasopharyngeal and laryngopharyngeal reflux with postnasal drip symptomatology in patients with and without rhinosinusitis Am J Rhinol 20 2006 283 289
5. S. Pawar, H.J. Lim, and M. Gill Treatment of postnasal drip with proton pump inhibitors Am J Rhinol 21 2007 695 701
6. J. Dent, H.B. El-Serag, and M.A. Wallander Epidemiology of gastro-oesophageal reflux disease: a systematic review Gut 54 2005 710 717
7. G.R. Locke, N.J. Talley, and S.L. Fett Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota Gastroenterology 112 1997 1448 1456
8. N. Shaheen, R. Hansen, and D. Morgan The burden of gastrointestinal and liver diseases, 2006 Am J Gastroenterol 101 2006 2128 2138
9. J.W. Frye, and M.F. Vaezi Extraesophageal GERD Gastroenterol Clin North Am 37 2008 845 858
10. M.F. Vaezi The role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease Aliment Pharmacol Ther 231 2006 40 49
11. P.J. Kahrilas, N.J. Shaheen, and M.F. Vaezi American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease Gastroenterology 135 2008 1383 1413
12. R. Kenneth DeVault DOC Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease Am J Gastroenterol 100 2005 190 200
13. C. Doonellan, N. Sharma, and C. Preston Medical treatment for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease Cochrane Database Syst Rev 2 2005 CD003245
14. M.F. Vaezi, J.E. Richter, and C.R. Stasney Treatment of chronic posterior laryngitis with esomeprazole: placebo controlled trial Laryngoscope 116 2006 254 260
15. M.A. Qadeer, C.O. Phillips, and A.R. Lopez Proton pump inhibitor therapy for suspected GERD-related laryngitis: a meta analysis of randomized controlled trials Am J Gastroenterol 101 2006 2646 2654
16. The American Lung Association Asthma Clinical Research Centers Efficacy of esomeprazole for treatment of poorly controlled asthma N Engl J Med 360 2009 1487 1499
17. T.O. Kiljander, S.M. Harding, and S.K. Field Effects of esomeprazole 40mg twice daily on asthma: a randomized placebo controlled tiral Am J Respir Crit Care Med 173 2006 1091 1097
18. A.B. Chang, T.J. Lasserson, and T.O. Kiljander Systematic review and meta-analysis of randomized controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux BMJ 332 2006 11 17
19. J.F. Piccirillo, D. Edwards, and A. Haiduk Psychometric and clinimetric validity of the 31-item rhinosinusitis outcome measure (RSOM-31) Am J Rhinol 9 1995 297 306
20. J.F. Piccirillo, M.G. Merritt, and M.L. Richards Psychometric and clinimetric validity of the 20-item sino-nasal outcome test (SNOT-20) Otolaryngol Head Neck Surg 126 2002 41 47
21. I.K. Wiklund, O. Junghard, and E. Grace Quality of life in reflux and dyspepsia patients Psychometric documentation of a new disease specific questionnaire (QOLRAD) Eur J Surg 164 1998 41 49
22. J.M. Pritchett, M. Aslam, and J.D. Slaughter Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy Clin Gastroenterol Hepatol 7 2009 743 748
23. S. Charbel, F. Khandwala, and M.F. Vaezi The role of esophageal pH monitoring in symptomatic patients on PPI therapy Am J Gastroenterol 100 2005 283 289
24. P.C. Belafsky, G.N. Postma, and J.A. Koufman Laryngopharyngeal reflux symptoms improve before changes in physical findings Laryngoscope 111 2001 979 981
25. H.B. El-Serag, and A. Sonnenberg Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans Gastroenterology 113 1997 755 760
26. B.D. Havemann, C.A. Henderson, and H.B. El-Serag The association between gastro-oesophageal reflux disease and asthma: a systematic review Gut 56 2007 1654 1664
27. M.F. Vaezi, D.M. Hicks, and T.I. Abelson Laryngeal signs and symptoms and gastroesophageal reflux disease: a critical assessment of cause and effect association Clin Gastroenterol Hepatol 1 2003 333 344
28. R. Shaker Protective mechanisms against supraesophageal GERD Clin Gastroenterol 30 2000 S3 S8
29. G. Champion, J.E. Richter, and M.F. Vaezi Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus Gastroenterology 107 1994 747 754
30. M.F. Vela, L. Camacho-Lobato, and R. Srinivasan Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole Gastroenterology 120 2001 1599 1606
31. A. Babaei, V. Bhargava, and S. Aalam Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging Aliment Pharmacol Ther 29 2009 863 870
32. O. Gursoy, D. Memi, and N. Sut Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients: a randomized, double-blind, placebo-controlled study Clin Drug Investig 28 2008 777 782
33. R.R. Kedika, R.F. Souza, and S.J. Spechler Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implication Dig Dis Sci 54 2009 2312 2317
34. D. Lapenna, S. de Gioia, and G. Ciofani Antioxidant properties of omeprazole FEBS Lett 382 1996 189 192
35. C. Blandizzi, M. Fornai, and R. Colucci Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage World J Gastroenterol 11 2005 4052 4060
36. J.H. Wandall Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation and translocation of cytochrome b-245 Gut 33 1992 617 621
37. O. Handa, N. Yoshida, and N. Fujita Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors Inflamm Res 55 2006 476 480
38. T. Sasaki, M. Yamaya, and H. Yasuda The proton pump inhibitor lansoprazole inhibits rhiovirus infection in cultured human tracheal epithelial cells Eur J Pharmacol 509 2005 201 210